AGIG NYSE Crude Petroleum & Natural Gas Financials FY2016βFY2025
Abundia Global Impact Group, Inc. had $0.4M of revenue in fiscal 2025, down 26.7% on the year before. Over five years, revenue changed β5.8% a year on average.
Last close Β· Oct 23, 2026
$1.01
5.7%Hi! I read Abundia Global Impact Group, Inc.βs latest annual report (fiscal 2025). Here is what stands out:
Good So-so Weak
Are sales growing?
β26.7%
No. Sales fell 26.7% last year.
Does it make a profit?
β7,173.0%
No. It lost money last year.
Does profit turn into cash?
β4,070.4%
No. It spent more cash than it brought in.
How healthy are the accounts?
4 / 8
Mixed. It passes 4 of 8 health tests.
How is the share priced?
β
No P/E: it made no profit over the last four quarters.
Rules of thumb on reported numbers. A starting point, not a recommendation.
Is it selling more, and how much does it keep?
In plain words: Every quarter, companies publish how much they sold and earned. These are the days Abundia Global Impact Group, Inc. did it, and the next one. Share prices often move a lot on those days.
Next results
November 18, 2026
Wednesday Β· in 23 days
| Date | Results for | Time | Source |
|---|---|---|---|
| Aug 7, 2026 | Q2 '26 | Before the market opens | 10-Q β |
| May 8, 2026 | Q1 '26 | Before the market opens | 10-Q β |
| Mar 23, 2026 | Q4 '25 | Before the market opens | 10-K β |
| Nov 10, 2025 | Q3 '25 | Before the market opens | 8-K β |
| Aug 15, 2025 | Q2 '25 | Time not announced | 10-Q β |
| May 9, 2025 | Q1 '25 | During market hours | 10-Q β |
| Feb 24, 2025 | Q4 '24 | Time not announced | 10-K β |
| Nov 14, 2024 | Q3 '24 | After the market closes | 10-Q β |
From SEC filings: the results press release (8-K) or, without one, the quarterly or annual report.
KIRA Β· Abundia Global Impact Group, Inc. had $0.4M of revenue in fiscal 2025, down 26.7% on the year before. Over five years, revenue changed β5.8% a year on average. Its operating margin was β7,001.3%, down 5,564.5Β pts: of every 100 in sales, about β7,001 is left after running the business.
In plain words: Revenue is all the money customers paid. The margins show how many cents of each dollar of sales are left over at each step: after making the product (gross), after running the business (operating) and after everything, tax included (net).
Revenue
Revenue
Margins, % of revenue
Margins, % of revenue
KIRA Β· Abundia Global Impact Group, Inc. lost $29.5M in fiscal 2025.
Loss periods are shown in red.
In plain words: Net income is the profit left after every cost and tax. Earnings per share (EPS) splits that profit across every share, so it shows what one share earned.
Net income
Net income
Diluted EPS
Diluted EPS
How much cash comes in, and where does it go?
KIRA Β· Free cash flow was β$16.7M in fiscal 2025, β4,070.4% of revenue.
Cash from operations minus capital spending.
In plain words: Profit on paper is not the same as cash in the bank. Free cash flow is the cash left after paying to run and maintain the business: the money it can hand back to shareholders, save or invest.
Free cash flow
Free cash flow
Cash from operations vs capital spending
Cash from operations vs capital spending
In plain words: Companies hand cash back in two ways: dividends (cash paid to shareholders) and buybacks (buying back their own shares, so each remaining share owns a bigger slice).
Dividends and buybacks
Diluted shares outstanding (annual)
KIRA Β· No open-market insider trades in the last 12 months.
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. βPlanβ marks trades under a pre-arranged Rule 10b5-1 plan.
In plain words: Insiders are the people who run or own a big part of the company. Buying with their own money can signal confidence; selling often has personal reasons, like taxes or diversifying.
Bought, 12 months
$0.0M
0 insiders
Sold, 12 months
$0.0M
0 insiders
Of sales under plans
β
$0.0M
No open-market insider trades in the last 12 months.
Can it carry its debts, and how well does it use its money?
KIRA Β· Abundia Global Impact Group, Inc. owes $5.4M more than it holds in cash.
Cash, debt and the ratios that show how comfortably Abundia Global Impact Group, Inc. can carry it.
In plain words: What the company owns and what it owes. More cash than debt is a cushion for bad times; a lot of debt leaves less room when business slows down.
Cash vs debt (incl. leases)
| Fiscal year end | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Cash and short-term investments | $4.9M | $4.5M | $4.1M | $0.5M | $4.8M |
| Debt incl. finance leases | β | β | β | $5.9M | $10.2M |
| Debt / equity | β | β | β | β | 0.5x |
| Interest coverage | β3,447.3x | β | β | β20.1x | β71.9x |
| Current ratio | 36.6x | 24.6x | 16.7x | 0.1x | 0.9x |
| Quick ratio | 36.6x | 24.6x | 16.7x | 0.1x | 0.9x |
| Total assets | $10.7M | $11.7M | $10.4M | $4.1M | $34.3M |
| Total liabilities | $0.4M | $0.4M | $0.4M | $6.2M | $13.8M |
| Shareholders' equity | $10.3M | $11.3M | $10.0M | β$2.1M | $20.6M |
| Net debt (β = net cash) | β | β | β | $5.3M | $5.4M |
KIRA Β· Its return on capital was β87.3%: every 100 invested in the business earned about β87 in a year.
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
In plain words: How much profit the business makes on the money put into it. A higher percentage means each dollar invested works harder.
Return on capital, equity and assets (annual)
KIRA Β· Abundia Global Impact Group, Inc. passes 4 of 8 financial health tests (Piotroski F-score).
Nine pass/fail tests of profitability, funding and efficiency. 8β9 is strong, 0β2 weak.
In plain words: Nine yes/no tests of financial health, one point each. A green tick is a pass: 7 to 9 points is solid, 0 to 3 is weak.
| Test | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net income is positive | β | β | β | β | β | β | β | β | β | β |
| Cash from operations is positive | β | β | β | β | β | β | β | β | β | β |
| Return on assets rose | β | β | β | β | β | β | β | β | β | β |
| Cash from operations exceeds net income | β | β | β | β | β | β | β | β | β | β |
| Debt fell relative to assets | β | β | β | β | β | β | β | β | β | β |
| Current ratio rose | β | β | β | β | β | β | β | β | β | β |
| Share count didn't rise | β | β | β | β | β | β | β | β | β | β |
| Gross margin rose | β | β | β | β | β | β | β | β | β | β |
| Revenue rose relative to assets | β | β | β | β | β | β | β | β | β | β |
| F-score | β / 3 | β / 6 | 5 / 7 | 2 / 7 | 2 / 7 | 4 / 7 | 3 / 7 | 2 / 7 | 2 / 7 | 4 / 8 |
| Accruals ratio | β45.7% | β6.1% | β8.0% | β24.0% | β45.6% | β3.9% | β4.6% | β31.4% | β23.2% | β111.3% |
| Altman Z'' | β41.19 | 3.23 | 28.58 | β29.28 | β20.57 | 5.92 | 10.30 | 2.72 | β35.17 | β8.78 |
Every number, year by year.
Amounts in USD. Hover a ratioβs name for its definition.
In plain words: Every number we have, year by year. Download it as a spreadsheet if you want to dig deeper.
| Fiscal year | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||||
| Revenue | β | $0.6M | $2.4M | $1.0M | $0.6M | $1.3M | $1.6M | $0.8M | $0.6M | $0.4M |
| Research and development | β | β | β | β | β | β | β | β | $1.7M | $0.8M |
| Operating income | β$2.6M | β$1.9M | β$0.3M | β$2.3M | β$4.2M | β$1.0M | β$0.8M | β$4.6M | β$8.0M | β$28.7M |
| Interest expense | β | $0.2M | β | $0.2M | $0.0M | $0.0M | β | β | $0.4M | $0.4M |
| Pretax income | β$2.6M | β$2.0M | β$0.3M | β$2.5M | β$4.0M | $1.0M | β$0.7M | β$3.2M | β$3.6M | β$29.5M |
| Net income | β$2.6M | β$2.0M | β$0.3M | β$2.5M | β$4.0M | β$1.0M | β$0.7M | β$3.2M | β$3.6M | β$29.5M |
| Net income to common | β | β$2.2M | β$0.5M | β$2.7M | β$4.3M | β$1.1M | β$0.7M | β | β$3.6M | β$29.5M |
| Diluted EPS | β$0.05 | β$0.04 | β$0.01 | β$0.52 | β$0.62 | β$0.11 | $0.07 | β$0.30 | β$0.11 | β$0.90 |
| Diluted shares | 0.05B | 0.05B | 0.06B | 0.01B | 0.01B | 0.01B | 0.01B | 0.01B | 0.03B | 0.03B |
| Cash flow | ||||||||||
| Cash from operations | β$1.3M | β$1.7M | $0.4M | β$0.7M | β$0.9M | β$0.7M | β$0.2M | $0.3M | β$1.9M | β$8.1M |
| Capital expenditure | β | β | β | β | β | β | β | β | β | $8.7M |
| Free cash flow | β | β | β | β | β | β | β | β | β | β$16.7M |
| Depreciation and amortization | $0.3M | $0.2M | $0.4M | $0.4M | $0.4M | $0.2M | $0.2M | $0.2M | $0.0M | $0.2M |
| Stock-based compensation | $0.1M | $0.3M | $0.1M | $0.2M | $0.4M | $0.3M | $0.2M | $0.2M | $0.1M | $1.5M |
| Share buybacks | $0.1M | β | β | β | β | β | β | β | β | β |
| Dividends paid | β | $0.1M | $0.2M | $0.2M | $0.2M | $0.0M | β | β | β | β |
| Dividends and buybacks | $0.1M | $0.1M | $0.2M | $0.2M | $0.2M | $0.0M | β | β | β | β |
| Balance sheet | ||||||||||
| Cash and short-term investments | $0.5M | $0.4M | $0.8M | $0.1M | $1.2M | $4.9M | $4.5M | $4.1M | $0.5M | $4.8M |
| Total debt | β | β | β | β | β | β | β | β | $5.9M | $10.2M |
| Deposits | β | β | β | β | $0.9M | $4.5M | $4.3M | $3.7M | $2.5M | $4.4M |
| Current assets | $0.5M | $0.7M | $1.0M | $0.2M | $1.4M | $5.2M | $4.8M | $4.2M | $0.9M | $6.3M |
| Current liabilities | $0.1M | $0.2M | $0.1M | $1.0M | $0.2M | $0.1M | $0.2M | $0.2M | $6.2M | $7.3M |
| Property and equipment, net | $2.5M | $6.8M | $6.9M | $6.4M | $5.0M | $4.8M | $4.6M | $1.6M | $0.0M | $11.3M |
| Goodwill | β | β | β | β | β | β | β | β | β | $13.2M |
| Intangible assets | β | β | β | β | β | β | β | β | β | $1.4M |
| Total assets | $2.9M | $7.6M | $7.8M | $7.1M | $6.8M | $10.7M | $11.7M | $10.4M | $4.1M | $34.3M |
| Total liabilities | $0.1M | $0.2M | $0.1M | $1.2M | $0.4M | $0.4M | $0.4M | $0.4M | $6.2M | $13.8M |
| Preferred stock | β | $0.0M | β | β | β | β | β | β | β | β |
| Shareholders' equity | $2.9M | $7.3M | $7.7M | $5.8M | $6.4M | $10.3M | $11.3M | $10.0M | β$2.1M | $20.6M |
| Margins | ||||||||||
| Operating margin | β | β297.6% | β14.3% | β233.8% | β757.3% | β77.7% | β47.5% | β576.9% | β1,436.8% | β7,001.3% |
| EBITDA margin | β | β272.0% | 0.8% | β189.9% | β691.3% | β59.3% | β34.9% | β555.8% | β1,434.0% | β6,950.4% |
| Net margin | β | β323.2% | β10.7% | β252.1% | β731.0% | β76.8% | β45.4% | β404.4% | β644.1% | β7,173.0% |
| FCF margin | β | β | β | β | β | β | β | β | β | β4,070.4% |
| Returns | ||||||||||
| Return on capital | β | β | β | β | β | β | β | β | β195.3% | β87.3% |
| Return on capital employed | β91.8% | β25.3% | β4.4% | β38.2% | β63.3% | β9.8% | β6.7% | β45.2% | 387.2% | β106.4% |
| Return on equity | β92.5% | β40.0% | β3.4% | β37.2% | β65.8% | β12.2% | β6.9% | β30.1% | β91.2% | β318.4% |
| Return on assets | β89.7% | β38.8% | β3.3% | β33.8% | β58.0% | β11.6% | β6.6% | β29.0% | β49.8% | β153.2% |
| Return on tangible equity | β92.5% | β29.7% | β6.4% | β47.0% | β66.3% | β10.3% | β6.6% | β32.1% | β | β492.7% |
| Growth | ||||||||||
| Revenue growth | β | β | 273.8% | β57.7% | β44.7% | 140.8% | 23.2% | β51.5% | β29.4% | β26.7% |
| EPS growth | β | β | β | β | β | β | β | β528.6% | β | β |
| Share count change | β | 4.7% | 12.5% | β91.3% | 31.5% | 39.4% | 3.0% | 8.3% | 194.7% | 3.4% |
| Financial health | ||||||||||
| Debt / equity | β | β | β | β | β | β | β | β | β | 0.5x |
| Interest coverage | β | β10.9x | β | β12.7x | β131.5x | β3,447.3x | β | β | β20.1x | β71.9x |
| Current ratio | 7.9x | 4.9x | 15.3x | 0.2x | 5.9x | 36.6x | 24.6x | 16.7x | 0.1x | 0.9x |
| Quick ratio | 7.9x | 4.9x | 15.3x | 0.2x | 5.9x | 36.6x | 24.6x | 16.7x | 0.1x | 0.9x |
| Capital allocation | ||||||||||
| Capex / revenue | β | β | β | β | β | β | β | β | β | 2,109.3% |
| Stock comp / revenue | β | 48.5% | 4.1% | 15.6% | 78.7% | 24.3% | 12.6% | 30.0% | 18.1% | 370.8% |
| Quality scores | ||||||||||
| Piotroski F-score | β | β | 5.0 | 2.0 | 2.0 | 4.0 | 3.0 | 2.0 | 2.0 | 4.0 |
| Altman Z'' | β41.2 | 3.2 | 28.6 | β29.3 | β20.6 | 5.9 | 10.3 | 2.7 | β35.2 | β8.8 |
| Accruals ratio | β45.7% | β6.1% | β8.0% | β24.0% | β45.6% | β3.9% | β4.6% | β31.4% | β23.2% | β111.3% |
Source: SEC EDGAR XBRL filings (CIK 0001156041). Data updated October 24, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only β not investment advice. Check the original filings before relying on any figure.
